The inhibition of TNF-α-induced leucocyte apoptosis by melatonin involves membrane receptor MT1/MT2 interaction

Journal of Pineal Research

Volumn 54, Issue 4, 2013, Pages 442-452

  Espino, Javier ^a   Rodríguez, Ana B ^a   Pariente, José A ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Cell death; Leucocytes; Melatonin; MT receptor; Protein kinases; Tumour necrosis factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACETYLCYSTEINE; CASPASE 3; CASPASE 8; CASPASE 9; CYCLOHEXIMIDE; FLICE INHIBITORY PROTEIN; LIPOCORTIN 5; LUZINDOLE; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN 2 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROPIDIUM IODIDE; PROTEIN BID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; MALE; NORMAL HUMAN; PROTEIN INTERACTION;

CELL DEATH; LEUCOCYTES; MELATONIN; MT RECEPTOR; PROTEIN KINASES; TUMOUR NECROSIS FACTOR-Α;

ADOLESCENT; ADULT; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; HUMANS; LEUKOCYTES; MELATONIN; MIDDLE AGED; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; RECEPTOR, MELATONIN, MT1; RECEPTOR, MELATONIN, MT2; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84879459992     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12042     Document Type: Article

References (47)

1. VARFOLOMEEV EE, ASHKENAZI A. Tumor necrosis factor: an apoptosis JuNKie? Cell 2004; 116:491-497.
2. FELDMANN M, MAINI RN. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases. Nat Med 2003; 9:1245-1250.
3. AGGARWAL BB. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3:745-756.
4. MICHEAU O, TSCHOPP J. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 2003; 114:181-190.
5. SUGARMAN BJ, AGGARWAL BB, HASS PE et al. Recombinant human tumor necrosis factor-alpha: Effects on proliferation of normal and transformed cells in vitro. Science 1985; 230:943-945.
6. YAMASHITA K, TAKAHASHI A, KOBAYASHI S et al. Caspases mediate tumor necrosis factor-alpha-induced neutrophil apoptosis and down-regulation of reactive oxygen production. Blood 1999; 93:674-685.
7. WANG L, DU F, WANG X. TNF-α induces two distinct caspase-8 activation pathways. Cell 2008; 133:693-703.
8. STEHLIK C, DE MARTIN R, KUMABASHIRI I et al. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 1998; 188:211-216.
9. CHEN C, EDELSTEIN LC, GELINAS C. The Rel/NF-kappaB family directly activates expression of the apoptosis inhibitor Bcl-x(L). Mol Cell Biol 2000; 20:2687-2695.
10. KREUZ S, SIEGMUND D, SCHEURICH P et al. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 2001; 21:3964-3973.
11. WANG CY, MAYO MW, KORNELUK RG et al. NF-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281:1680-1683.
12. TAN DX, HARDELAND R, MANCHESTER LC et al. The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness. Biol Rev Camb Philos Soc 2010; 85:607-623.
13. TAN DX, CHEN LD, POEGGELER B et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1:57-60.
14. GALANO A, TAN DX, REITER RJ. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51:1-16.
15. GALANO A, TAN DX, REITER RJ. The free radical scavenging activities of melatonin's metabolites, AMFK and AMK. J Pineal Res 2013; doi: 10.1111/jpi.12010 [Epub ahead of print].
16. CARRILLO-VICO A, GARCÍA-MAURIÑO S, CALVO JR et al. Melatonin counteracts the inhibitory effect of PGE2 on IL-2 production in human lymphocytes via its mt1 membrane receptor. FASEB J 2003; 17:755-757.
17. DEL SOLE MJ, SANDE PH, FERNANDEZ DC et al. Therapeutic benefit of melatonin in experimental feline uveitis. J Pineal Res 2012; 52:29-37.
18. BEJARANO I, REDONDO PC, ESPINO J et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46:392-400.
19. HILL SM, FRASCH T, XIANG S et al. Molecular mechanisms of melatonin anticancer effects. Integr Cancer Ther 2009; 8:337-346.
20. MARTÍN V, SAINZ RM, ANTOLÍN I et al. Several antioxidant pathways are involved in astrocyte protection by melatonin. J Pineal Res 2002; 33:204-212.
21. SAINZ RM, MAYO JC, RODRÍGUEZ C et al. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60:1407-1426.
22. ESPINO J, BEJARANO I, PAREDES SD et al. Melatonin counteracts alterations in oxidative metabolism and cell viability induced by intracellular calcium overload in human leucocytes: Changes with age. Basic Clin Pharmacol Toxicol 2010; 107:590-597.
23. ESPINO J, BEJARANO I, REDONDO PC et al. Melatonin reduces caspase activation induced by calcium signaling in human leukocytes: Evidence for the involvement of mitochondria and Bax activation. J Membrane Biol 2010; 233:105-118.
24. MARTIN M, MACIAS M, ESCAMES G et al. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 2000; 28:242-248.
25. ESPINO J, BEJARANO I, PAREDES SD et al. Melatonin is able to delay endoplasmic reticulum stress-induced apoptosis in leukocytes from elderly humans. Age (Dordr) 2011; 33: 497-507.
26. 2+, and lipids insults in NARP cybrids: a potential therapeutic target for melatonin. J Pineal Res 2012; 52:95-106.
27. DAS A, MCDOWELL M, PAVA MJ et al. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-α toxicity involves membrane melatonin receptors. J Pineal Res 2010; 48:157-169.
28. ESPINO J, ORTIZ A, BEJARANO I et al. Melatonin protects human spermatozoa from apoptosis via melatonin receptorand extracellular signal-regulated kinase-mediated pathways. Fertil Steril 2011; 95:2290-2296.
29. CARRILLO-VICO A, REITER RJ, LARDONE PJ et al. The modulatory role of melatonin on immune responsiveness. Curr Opin Investig Drugs 2006; 7:423-431.
30. ESPINO J, BEJARANO I, PAREDES SD et al. Protective effect of melatonin against human leukocyte apoptosis induced by intracellular calcium overload: relation with its antioxidant actions. J Pineal Res 2011; 51:195-206.
31. TAN DX, MANCHESTER LC, REITER RJ et al. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochim Biophys Acta 1999; 1472:206-214.
32. BARRETT P, BOLBOREA M. Molecular pathways involved in seasonal body weight and reproductive responses by melatonin. J Pineal Res 2012; 52:376-388.
33. EMMEND€ORFFER A, HECHT M, LOHMANN-MATTHES ML et al. A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods 1990; 131:269-275.
34. LI P, NIJHAWAN D, BUDIHARDJO I et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91:479-489.
35. GEERING B, GURZELER U, FEDERZONI E et al. A novel TNFR1-triggered apoptosis pathway mediated by class IA PI3Ks in neutrophils. Blood 2011; 117:5953-5962.
36. MUZIO M, STOCKWELL BR, STENNICKE HR et al. An induced proximity model for caspase-8 activation. J Biol Chem 1998; 273:2926-2930.
37. COWBURN AS, WHITE JF, DEIGHTON J et al. z-VAD-fmk augmentation of TNF alpha-stimulated neutrophil apoptosis is compound specific and does not involve the generation of reactive oxygen species. Blood 2005; 105:2970-2972.
38. PAREDES SD, MARCHENA AM, BEJARANO I et al. Melatonin and tryptophan affect the activity-rest rhythm, core and peripheral temperatures, and interleukin levels in the ringdove: changes with age. J Gerontol A Biol Sci Med Sci 2009; 64:340-350.
39. PAREDES SD, BEJARANO I, TERRÓN MP et al. Melatonin and tryptophan counteract lipid peroxidation and modulate superoxide dismutase activity in ringdove heterophils in vivo. Effect of antigen-induced activation and age. Age (Dordr) 2009; 31:179-188.
40. TERRÓN MP, DELGADO J, PAREDES SD et al. Effect of melatonin and tryptophan on humoral immunity in young and old ringdoves (Streptopelia risoria). Exp Gerontol 2009; 44:653-658.
41. RADOGNA F, CRISTOFANON S, PATERNOSTER L et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008; 44:316-325.
42. JUNTTILA MR, LI SP, WESTERMARCK J. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. FASEB J 2008; 22:954-965.
43. XIA Z, DICKENS M, RAINGEAUD J et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 1995; 270:1326-1331.
44. KURLAND JF, VOEHRINGER DW, MEYN RE. The MEK/ERK pathway acts upstream of NF kappa B1 (p50) homodimer activity and Bcl-2 expression in a murine B-cell lymphoma cell line. MEK inhibition restores radiation-induced apoptosis. J Biol Chem 2003; 278:32465-32470.
45. MONICK MM, POWERS LS, BARRET CW et al. Constitutive ERK MAPK activity regulates macrophage ATP production and mitochondrial integrity. J Immunol 2008; 180:7485-7496.
46. LUCHETTI F, BETTI M, CANONICO B et al. ERK MAPK activation mediates the antiapoptotic signaling of melatonin in UVBstressed U937 cells. Free Radic Biol Med 2009; 46:339-351.
47. KONG PJ, BYUN JS, LIM SY et al. Melatonin induces Akt phosphorylation through melatonin receptor- and PI3Kdependent pathways in primary astrocytes. Korean J Physiol Pharmacol 2008; 12:37-41.